Lu Qi

1.6k total citations
52 papers, 1.1k citations indexed

About

Lu Qi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lu Qi has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Lu Qi's work include Cancer-related molecular mechanisms research (10 papers), Ferroptosis and cancer prognosis (7 papers) and Immunotherapy and Immune Responses (7 papers). Lu Qi is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Ferroptosis and cancer prognosis (7 papers) and Immunotherapy and Immune Responses (7 papers). Lu Qi collaborates with scholars based in China, United States and Switzerland. Lu Qi's co-authors include Yanqing Ding, Yanqing Ding, Jin Sun, Kaiyuan Wang, Hao Ye, Zhonggui He, Wenting Liao, Jian Zhao, Tingting Li and Haotian Zhang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Lu Qi

48 papers receiving 1.1k citations

Peers

Lu Qi

ONCOL

IMMUN

Rafał Sądej Poland

Alice Turdo Italy

Yu Fan China

Sheng Chen China

Shangzhi Xie China

Alessio Biagioni Italy

Fiona Furlong Ireland

Alan Guichard France

Haoyu Ruan China

Constantinos Alifieris Greece

Rafał Sądej Poland

Lu Qi

560 ×0.8

256 ×0.6

339 ×1.5

ONCOL

124 ×0.6

141 ×0.8

IMMUN

Citations per year, relative to Lu Qi Lu Qi (= 1×) peers Rafał Sądej

Countries citing papers authored by Lu Qi

Since Specialization

Citations

This map shows the geographic impact of Lu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Qi more than expected).

Fields of papers citing papers by Lu Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Qi. The network helps show where Lu Qi may publish in the future.

Co-authorship network of co-authors of Lu Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Qi. A scholar is included among the top collaborators of Lu Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Qi. Lu Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qi, Xin, Lu Qi, Bo Li, et al.. (2025). Videos in short video sharing platforms as a source of information on bipolar disorder: a cross-sectional content analysis study. Frontiers in Public Health. 13. 1627885–1627885.

Zhao, Jian, Xinyan Lv, Lu Qi, et al.. (2025). Engineered platelet-derived exosomal spheres for enhanced tumor penetration and extended circulation in melanoma immunotherapy. Acta Pharmaceutica Sinica B. 15(7). 3756–3766. 2 indexed citations

Qi, Lu, et al.. (2025). Factors affecting the postoperative survival rate of obese Asian patients with endometrial cancer. Journal of Obstetrics and Gynaecology. 45(1). 2480856–2480856.

Qi, Lu, Xiangyu Pan, Xuelan Chen, et al.. (2023). COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma. Oncogenesis. 12(1). 5–5. 7 indexed citations

Qi, Lu, Tian Liu, Jian Zhao, et al.. (2023). Revolutionizing cancer treatment: The power of cell-based drug delivery systems. Journal of Controlled Release. 361. 604–620. 19 indexed citations

He, Xinyu, Wen-Yu Lyu, Mu‐Yang Huang, et al.. (2023). Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells. Chinese Journal of Natural Medicines. 21(11). 842–851. 4 indexed citations

Yang, Shengjie, et al.. (2023). Promoting proliferation and tumorigenesis of breast cancer: KCND2’s significance as a prognostic factor. Functional & Integrative Genomics. 23(3). 257–257. 2 indexed citations

Liang, Ying, Lu Qi, Wei Li, et al.. (2021). Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network. Nucleic Acids Research. 49(15). 8556–8572. 42 indexed citations

Tan, Ping, Manli Wang, Yiyun Wang, et al.. (2021). SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis. Oncogene. 40(42). 6081–6092. 41 indexed citations

10.

Qi, Lu, Shijie Tang, Zhijian Li, et al.. (2020). Integrated RNA Sequencing and Single-Cell Mass Cytometry Reveal a Novel Role of LncRNA HOXA-AS2 in Tumorigenesis and Stemness of Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Qi, Lu, Fuyao Song, & Yanqing Ding. (2020). Regulatory Mechanism of ITGBL1 in the Metastasis of Colorectal Cancer. Frontiers in Oncology. 10. 259–259. 10 indexed citations

12.

Ye, Hao, Kaiyuan Wang, Lu Qi, et al.. (2020). Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition. Biomaterials. 242. 119932–119932. 106 indexed citations

13.

Wang, Feifei, Xiaohui Zhu, Kun Zhou, et al.. (2019). FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression. Cell Death and Disease. 10(5). 351–351. 29 indexed citations

14.

Qi, Lu & Yanqing Ding. (2018). TNK2 as a key drug target for the treatment of metastatic colorectal cancer. International Journal of Biological Macromolecules. 119. 48–52. 8 indexed citations

15.

Qi, Lu & Yanqing Ding. (2018). Analysis of metastasis associated signal regulatory network in colorectal cancer. Biochemical and Biophysical Research Communications. 501(1). 113–118. 13 indexed citations

16.

Zhou, Rui, Chen Liu, Yaofeng Wang, et al.. (2017). MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression. Cell Death and Disease. 8(12). 3213–3213. 74 indexed citations

17.

Qi, Lu, Wenjuan Zhang, Zhiqiang Cheng, Na Tang, & Yanqing Ding. (2017). Study on molecular mechanism of ANOS1 promoting development of colorectal cancer. PLoS ONE. 12(8). e0182964–e0182964. 10 indexed citations

18.

Liao, Wenting, Tingting Li, Zheng-Gen Wang, et al.. (2013). microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2. Clinical Cancer Research. 19(17). 4662–4672. 99 indexed citations

19.

Liao, Wenting, Y. Ye, Tingting Li, et al.. (2013). MicroRNA‐30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. The Journal of Pathology. 232(4). 415–427. 125 indexed citations

20.

Qi, Lu & Yanqing Ding. (2013). Potential antitumor mechanisms of phenothiazine drugs. Science China Life Sciences. 56(11). 1020–1027. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact